Helmholtz Zentrum für Infektionsforschung Repository >
publications of the TwinCore unit Infection immunology >
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.
this identifier to cite or link
to this item:
|Title: ||Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.|
|Affiliation: ||Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.|
|Citation: ||Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. 2011, 121 (7):2570-82 J. Clin. Invest.|
|Journal: ||The Journal of clinical investigation|
|Issue Date: ||1-Jul-2011 |
|PubMed ID: ||21646722|
|Abstract: ||Vaccination using DCs pulsed with tumor lysates or specific tumor-associated peptides has so far yielded limited clinical success for cancer treatment, due mainly to the low immunogenicity of tumor-associated antigens. In this study, we have identified intratumoral virus-induced inflammation as a precondition for effective antitumor DC vaccination in mice. Administration of a tumor-targeted DC vaccine during ongoing virus-induced tumor inflammation, a regimen referred to as oncolysis-assisted DC vaccination (ODC), elicited potent antitumoral CD8+ T cell responses. This potent effect was not replicated by TLR activation outside the context of viral infection. ODC-elicited immune responses mediated marked tumor regression and successful eradication of preestablished lung colonies, an essential prerequisite for potentially treating metastatic cancers. Unexpectedly, depletion of Tregs during ODC did not enhance therapeutic efficacy; rather, it abrogated antitumor cytotoxicity. This phenomenon could be attributed to a compensatory induction of myeloid-derived suppressor cells in Treg-depleted and thus vigorously inflamed tumors, which prevented ODC-mediated immune responses. Consequently, Tregs are not only general suppressors of immune responses, but are essential for the therapeutic success of multimodal and temporally fine-adjusted vaccination strategies. Our results highlight tumor-targeting, replication-competent viruses as attractive tools for eliciting effective antitumor responses upon DC vaccination.|
Mice, Inbred Strains
|Appears in Collections: ||publications of the TwinCore unit Infection immunology|
|Files in This Item:|
|Woller et al_final.pdf||allowed publisher's PDF||1824Kb||Adobe PDF|
|Related articles on PubMed|
Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination.
Samadi-Foroushani M, Vahabpour R, Memarnejadian A, Namdar A, Khamisabadi M, Sadat SM, Asgarian-Omran H, Azadmanesh K, Kokhaei P, Aghasadeghi MR, Hadjati J
|See all 105 articles|
This item is licensed under a Creative Commons License
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.